We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Modulation of Redox Environment Increases Breast Cancer Aggressiveness

By Gerald M. Slutzky, PhD
Posted on 16 Nov 2016
Print article
Image: The photomicrograph shows that a less aggressive tumor turns into a more aggressive tumor when artificially made to increase its manganese superoxide dismutase (MnSOD) levels (Photo courtesy of the National University of Singapore).
Image: The photomicrograph shows that a less aggressive tumor turns into a more aggressive tumor when artificially made to increase its manganese superoxide dismutase (MnSOD) levels (Photo courtesy of the National University of Singapore).
Cancer researchers have identified an enzyme that promotes the transition of breast tissue from epithelial (non-cancerous) to mesenchymal (metastatic cancer-like) modes during the development of invasive triple negative breast cancer.

Since analysis of breast cancers in The Cancer Genome Atlas database had revealed strong positive correlation between a tumor's EMT (epithelial - mesenchymal transition) score and the expression of the manganese superoxide dismutase (MnSOD) enzyme, investigators at the National University of Singapore (Singapore) sought to assess the involvement of MnSOD during the switch between epithelial-like and mesenchymal-like phenotypes in breast carcinomas.

As a member of the iron/manganese superoxide dismutase family, this enzyme transforms toxic superoxide, a byproduct of the mitochondrial electron transport chain, into hydrogen peroxide and diatomic oxygen. This function allows SOD2 to clear mitochondrial reactive oxygen species (ROS) and, as a result, confer protection against cell death. As a result, this protein plays an anti-apoptotic and pro-carcinogenic role against oxidative stress, ionizing radiation, and inflammatory cytokines.

The investigators reported in the August 2016 issue of the journal Antioxidants & Redox Signaling that they had observed the overexpression of MnSOD in mesenchymal-like breast cancers that exhibited increased migratory, invasive, and metastatic capacities. On the other hand, repression of MnSOD induced an epithelial phenotype with a reduction in EMT markers and cells' scattering, invasive, and motile capacity.

The positive correlation between MnSOD and EMT score was significant and consistent across all breast cancer subtypes. Similarly, a positive correlation of EMT score and MnSOD expression was observed in established cell lines derived from breast cancers exhibiting phenotypes ranging from the most epithelial to the most mesenchymal.

The investigators proposed that at the mechanistic level MnSOD appeared to drive epithelial to mesenchymal transition via its ability to modulate the cellular redox environment by adjusting the ratio of superoxide to hydrogen peroxide.

"By suppressing MnSOD expression or its activity in triple negative breast cancer patients, we are able to make the tumor cells less aggressive and more sensitive to chemotherapy," said senior author Dr. Alan Prem Kumar, principal associate in the Cancer Science Institute of Singapore at the National University of Singapore.

Related Links:
National University of Singapore

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Piezoelectric Micropump
Disc Pump

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.